Milestone Pharmaceuticals Inc. Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four
Milestone Pharmaceuticals Inc. (MIST) had Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four of $175.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-29.
Discontinued › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour · last filed 2021-03-29
- 2020-12-31: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $175.00K.
- 2020-09-30: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $167.00K.
| Period end | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four |
|---|---|
| 2020-12-31 | $175.00K 10-K · filed 2021-03-29 |
| 2020-09-30 | $167.00K 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |